Actinogen Medical Ltd (ACW) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
October 2018
65
About the Report
About the Report
Summary
Actinogen Medical Ltd (Actinogen), formerly Actinogen Ltd is a biotechnology company that develops novel treatments for alzheimer's disease and the cognitive decline associated with neurodegenerative diseases and metabolic diseases. The company's xanamem is a novel drug under development for the treatment of Alzheimer's disease which is designed to block the production of cortisol in the brain. It also develops drugs for the treatment of diabetes-cognitive dysfunction, cognitive dysfunction in parkinson's disease, post traumatic stress disorder, cognitive dysfunction in schizophrenia and depression, and cardiovascular disease-post myocardial infarction. Actinogen partners with other research companies to conduct clinical trials. The company operates in Australia. Actinogen is headquartered in Sydney, New South Wales, Australia.
Actinogen Medical Ltd (ACW)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Actinogen Medical Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Actinogen Medical Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Actinogen Medical Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Actinogen Medical Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Actinogen Medical Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Actinogen Medical Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Actinogen Medical Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Private Equity 11
Actinogen Medical to Raise USD11.4 Million in Private Placement of Shares 11
Partnerships 13
MindMate and Actinogen Medical Enter into Agreement 13
Actinogen Enters into Research Agreement with Curtin University 14
Equity Offering 15
Actinogen Medical Raises USD0.4 Million in Share Purchase Plan 15
Actinogen Medical Raises USD0.7 Million in Share Purchase Plan 17
Actinogen Medical to Raise USD4 Million in Private Placement of Shares 18
Actinogen Prices Rights Offering of Shares for USD1 Million 19
Actinogen Raises USD8 Million in Private Placement of Shares 20
Actinogen Completes Private Placement Of Shares For USD 1.4 Million 21
Actinogen Completes Private Placement Of Shares For USD 0.06 Million 22
Actinogen Withdraws Rights Offering Of Shares For USD 0.5 Million 23
Acquisition 24
Actinogen Acquires Corticrine 24
Actinogen Medical Ltd-Key Competitors 25
Actinogen Medical Ltd-Key Employees 26
Actinogen Medical Ltd-Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 28
Financial Announcements 28
Jan 31, 2018: Actinogen Medical: December 2017 Quarterly Report 28
Oct 30, 2017: Actinogen Medical: September Quarterly Update 30
Corporate Communications 32
Aug 14, 2017: Actinogen Medical announces Resignation of Director 32
Product News 33
12/01/2017: Amgen Pioneer Dr George Morstyn Joins Actinogen Board 33
10/30/2017: Actinogen Medical: September Quarterly Update 34
10/16/2017: Actinogen to be Showcased at Key Conferences 36
07/19/2017: Actinogen Medical presenting at Bioshares Biotech 2017 Summit 37
04/26/2017: Actinogen provides March quarterly update 38
02/27/2017: Actinogen announce Medical Half-Year Results 40
02/06/2018: Actinogen Medical: New data supports link between stress hormone cortisol and worsening cognition 42
Clinical Trials 43
May 31, 2018: Actinogen Medical to present at BIO International 2018 43
May 23, 2018: Actinogen Medical: Interim Analysis Recommends Continuation of XanADu Without Change 44
Apr 26, 2018: Actinogen Medical: March 2018 Quarterly Report 45
Mar 21, 2018: Mid-Way Point Reached in Landmark Alzheimer's Trial-XanADu 47
Feb 12, 2018: Actinogen Medical: Strong Recruitment Progress in Alzheimer's Trial 48
Nov 29, 2017: Early Efficacy and Safety Data Read-Out Planned for Alzheimer's Trial 49
Nov 22, 2017: Leading Alzheimer's Researchers to Address Shareholders 50
Sep 07, 2017: Actinogen Medical: First patient completes landmark Alzheimer's disease trial 51
Aug 16, 2017: First UK patient treated in ground-breaking Alzheimer's clinical trial 52
Jul 26, 2017: Actinogen Medical Provides Update on Xanamem 53
Jun 22, 2017: First US patients treated in landmark Alzheimers disease trial 55
Jun 01, 2017: First UK site goes live in global Alzheimer's disease clinical trial 56
May 16, 2017: First patient treated in landmark Alzheimer's disease clinical trial 57
Mar 08, 2017: TGA Regulatory Approval Received for Alzheimer's Phase II Trial 59
Feb 09, 2017: Xanamem research published in prestigious medical journal 60
Jan 10, 2017: UK Regulatory Approval for Alzheimer's Disease Clinical Trial-XanADu 61
Jan 03, 2017: FDA Approval to Commence Alzheimers Disease Clinical Trial 62
Other Significant Developments 63
Jul 25, 2018: Actinogen Medical: June 2018 quarterly report 63
Appendix 65
Methodology 65
About GlobalData 65
Contact Us 65
Disclaimer 65
List of Figure
List of Figures
Actinogen Medical Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Actinogen Medical Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Actinogen Medical Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Actinogen Medical Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Actinogen Medical Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Actinogen Medical Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Actinogen Medical Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Actinogen Medical Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
List of Table
List of Tables
Actinogen Medical Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Actinogen Medical Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Actinogen Medical Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Actinogen Medical Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Actinogen Medical Ltd, Deals By Therapy Area, 2012 to YTD 2018 9
Actinogen Medical Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Actinogen Medical to Raise USD11.4 Million in Private Placement of Shares 11
MindMate and Actinogen Medical Enter into Agreement 13
Actinogen Enters into Research Agreement with Curtin University 14
Actinogen Medical Raises USD0.4 Million in Share Purchase Plan 15
Actinogen Medical Raises USD0.7 Million in Share Purchase Plan 17
Actinogen Medical to Raise USD4 Million in Private Placement of Shares 18
Actinogen Prices Rights Offering of Shares for USD1 Million 19
Actinogen Raises USD8 Million in Private Placement of Shares 20
Actinogen Completes Private Placement Of Shares For USD 1.4 Million 21
Actinogen Completes Private Placement Of Shares For USD 0.06 Million 22
Actinogen Withdraws Rights Offering Of Shares For USD 0.5 Million 23
Actinogen Acquires Corticrine 24
Actinogen Medical Ltd, Key Competitors 25
Actinogen Medical Ltd, Key Employees 26
Actinogen Medical Ltd, Subsidiaries 27
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.